Palliative care for people with non-malignant lung disease: summary of current evidence and future direction [PDF]
, 2013 Background: The physical and psychosocial needs of patients with chronic non-malignant lung disease are comparable to those with lung cancer. This article will focus on chronic obstructive pulmonary disease, interstitial lung disease and cystic fibrosis ...
Boland, Jason +5 more
core +1 more source
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
European Respiratory Review, 2019 Two antifibrotic medications (nintedanib and pirfenidone) were recommended (conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the 2015 IPF evidence-based guidelines.
Bridget F. Collins, Ganesh Raghu
doaj +1 more source
YouTube-videos for patient education in lymphangioleiomyomatosis?
Respiratory Research, 2022 Background The Internet is commonly used by patients to acquire health information. To date, no studies have evaluated the quality of information available on YouTube regarding lymphangioleiomyomatosis (LAM).
Finn M. Wilkens +7 more
doaj +1 more source
Exploring the Versatility of Zero-Shot CLIP for Interstitial Lung Disease Classification [PDF]
arXiv, 2023 Interstitial lung diseases (ILD) present diagnostic challenges due to their varied manifestations and overlapping imaging features. To address this, we propose a machine learning approach that utilizes CLIP, a multimodal (image and text) self-supervised model, for ILD classification.
arxiv
Lung Transplant for Interstitial Lung Diseases [PDF]
, 2019 Lung transplant is an important treatment modality for select cases of advanced interstitial lung disease. However, the pre- and postoperative management requires several unique considerations.
Afshar, Kamyar +2 more
core +2 more sources
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. [PDF]
, 2021 Interstitial lung disease (ILDs) that are known as diffuse parenchymal lung diseases (DPLDs) lead to the damage of alveolar epithelium and lung parenchyma culminating into inflammation and widespread fibrosis.
Andrisani, D +13 more
core +1 more source
The role of nailfold capillaroscopy in interstitial lung diseases - Can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases? [PDF]
, 2015 Introduction: Nailfold capillaroscopy (NFC) is a non-invasive diagnostic test that is mostly used for early diagnosis of collagen tissue diseases (CTDs). We aimed to evaluate whether NFC findings could be a clue for discriminating idiopathic interstitial
Altınışık, Göksel +4 more
core +1 more source
Frontiers in Oncology, 2023 BackgroundAsbestos exposure is closely related to the occurrence and development of various malignancies. This prospective cohort study aimed to evaluate the incidence rate and potential risk factors in a cohort of asbestosis patients in China.MethodsThe
Jingwei Wang +7 more
doaj +1 more source
CNN-based Classification Framework for Lung Tissues with Auxiliary Information [PDF]
arXiv, 2022 Interstitial lung diseases are a large group of heterogeneous diseases characterized by different degrees of alveolitis and pulmonary fibrosis. Accurately diagnosing these diseases has significant guiding value for formulating treatment plans. Although previous work has produced impressive results in classifying interstitial lung diseases, there is ...
arxiv
Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
Medical Sciences, 2018 Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias.
Estrella Fernández Fabrellas +3 more
doaj +1 more source